A phase I trial of 5-aza-2'-deoxycytidine (DAC) and sodium phenylbutyrate in patients with solid tumors
Phase of Trial: Phase I
Latest Information Update: 22 Aug 2007
At a glance
- Drugs Decitabine (Primary) ; Sodium phenylbutyrate (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Aug 2007 New trial record.